RegentAtlantic Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $82K | Hold |
10,205
| – | – | ﹤0.01% | 655 |
|
|
2022
Q2 | $77K | Hold |
10,205
| – | – | ﹤0.01% | 664 |
|
|
2022
Q1 | $96K | Hold |
10,205
| – | – | ﹤0.01% | 676 |
|
|
2021
Q4 | $82K | Sell |
10,205
-2,000
| -16% | -$16.1K | ﹤0.01% | 677 |
|
|
2021
Q3 | $119K | Buy |
+12,205
| New | +$119K | ﹤0.01% | 647 |
|
|
2017
Q2 | – | Sell |
-7,083
| Closed | -$227K | – | 411 |
|
|
2017
Q1 | $227K | Sell |
7,083
-6,647
| -48% | -$213K | 0.02% | 373 |
|
|
2016
Q4 | $498K | Sell |
13,730
-9,205
| -40% | -$334K | 0.05% | 270 |
|
|
2016
Q3 | $1.06M | Sell |
22,935
-8,948
| -28% | -$412K | 0.11% | 183 |
|
|
2016
Q2 | $1.6M | Sell |
31,883
-7,153
| -18% | -$359K | 0.15% | 140 |
|
|
2016
Q1 | $289K | Sell |
39,036
-5,294
| -12% | -$39.2K | 0.03% | 321 |
|
|
2015
Q4 | $2.91M | Sell |
44,330
-23,083
| -34% | -$1.52M | 0.31% | 91 |
|
|
2015
Q3 | $3.81M | Sell |
67,413
-20,601
| -23% | -$1.16M | 0.37% | 72 |
|
|
2015
Q2 | $5.2M | Buy |
88,014
+4,591
| +6% | +$271K | 0.46% | 54 |
|
|
2015
Q1 | $5.2M | Buy |
83,423
+12,472
| +18% | +$777K | 0.46% | 55 |
|
|
2014
Q4 | $4.08M | Buy |
70,951
+11,617
| +20% | +$668K | 0.35% | 81 |
|
|
2014
Q3 | $3.19M | Buy |
59,334
+47,049
| +383% | +$2.53M | 0.3% | 86 |
|
|
2014
Q2 | $644K | Sell |
12,285
-336
| -3% | -$17.6K | 0.06% | 224 |
|
|
2014
Q1 | $667K | Sell |
12,621
-4,230
| -25% | -$224K | 0.07% | 217 |
|
|
2013
Q4 | $675K | Sell |
16,851
-4,145
| -20% | -$166K | 0.07% | 219 |
|
|
2013
Q3 | $793K | Sell |
20,996
-2,837
| -12% | -$107K | 0.09% | 184 |
|
|
2013
Q2 | $930K | Buy |
+23,833
| New | +$930K | 0.11% | 159 |
|